For many, conventional cancer treatments
are lifesaving. But when
healthy cells are caught in the crossfire,
these same treatments can substantially
decrease patients’ quality
of life. Enter Plectonic, a start-up
with a game-changing approach:
DNA nanoswitches that enable the
body’s own immune system to target
cancer cells without harming
healthy cells.